Hunan Fangsheng Pharmaceutical Co., Ltd.SSE: 603998

Announcement on Change of ""Drug Manufacturing License"

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

Hunan Fangsheng Pharmaceutical Co., Ltd. has announced a change to its Drug Manufacturing License. The license's validity has been extended and production details have been updated, including new production lines and products. The company assures that these changes will not impact its current production capacity or financial performance significantly. Investors are advised to remain cautious due to the inherent risks associated with pharmaceutical product development.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Fangsheng Pharmaceutical

Later from Hunan Fangsheng Pharmaceutical

All Hunan Fangsheng Pharmaceutical news releases